-
Kymera Therapeutics' (KYMR) "Outperform" Rating Reiterated at Leerink Partners
Source: Buzz FX / 27 Dec 2024 08:46:12 America/New_York
Kymera Therapeutics' (KYMR) "Outperform" Rating Reiterated at Leerink Partners Written by MarketBeat December 27, 2024 Share Link copied to clipboard. Kymera Therapeutics ( NASDAQ:KYMR - Get Free Report ) 's stock had its "outperform" ratin
Read more...